-
Signature
-
/s/ Eric R. Waller, Attorney-in-Fact
-
Stock symbol
-
TT
-
Transactions as of
-
Jun 5, 2024
-
Transactions value $
-
-$4,911,727
-
Form type
-
4
-
Date filed
-
6/7/2024, 04:12 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
TT |
Ordinary Shares |
Options Exercise |
$231K |
+3.69K |
+4.15% |
$62.53 |
92.6K |
Jun 5, 2024 |
Direct |
|
transaction |
TT |
Ordinary Shares |
Sale |
-$1.18M |
-3.69K |
-3.98% |
$321.33 |
88.9K |
Jun 5, 2024 |
Direct |
F1, F2 |
transaction |
TT |
Ordinary Shares |
Options Exercise |
$1.11M |
+15.8K |
+17.73% |
$70.22 |
105K |
Jun 5, 2024 |
Direct |
|
transaction |
TT |
Ordinary Shares |
Sale |
-$2.53M |
-7.88K |
-7.53% |
$321.33 |
96.8K |
Jun 5, 2024 |
Direct |
F1, F3 |
transaction |
TT |
Ordinary Shares |
Sale |
-$2.53M |
-7.88K |
-8.14% |
$321.34 |
88.9K |
Jun 5, 2024 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
TT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-3.69K |
-100% |
$0.00* |
0 |
Jun 5, 2024 |
Ordinary Shares |
3.69K |
$62.53 |
Direct |
F5 |
transaction |
TT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-15.8K |
-66.67% |
$0.00 |
7.88K |
Jun 5, 2024 |
Ordinary Shares |
15.8K |
$70.22 |
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: